SSR180711 hydrochloride is a selective, reversible, and orally active partial agonist of α7 nicotinic acetylcholine receptors (α7 nAChRs); it enhances glutamatergic neurotransmission, acetylcholine release, and long-term potentiation (LTP) in the hippocampus; it is used in research for its potential therapeutic effects in cognitive and neuropsychiatric disorders associated with α7 nAChR dysfunction.